Central DE Medicamentos Y Artigos M Pharmaceutical Import Profile — Mozambique (DGFT 2022–2026)

Name: Central DE Medicamentos Y Artigos M Pharmaceutical Import Records from India — 2 Products, $450.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Central DE Medicamentos Y Artigos M — Pharmaceutical Importer Profile (2026) | 2 Products, $450.0K Trade | TransData Nexus

Central DE Medicamentos Y Artigos M

Pharmaceutical Importer · Mozambique · Tuberculosis Medications Focus · $450.0K Total Trade · DGFT Verified

Central DE Medicamentos Y Artigos M is a pharmaceutical importer based in Mozambique with a total trade value of $450.0K across 2 products in 1 therapeutic categories. Based on 9 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Central DE Medicamentos Y Artigos M sources from 2 verified Indian suppliers, with Lupin Limited accounting for 58.2% of imports.

Central DE Medicamentos Y Artigos M — Import Portfolio & Supplier Network

Central DE Medicamentos Y Artigos M import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Central DE Medicamentos Y Artigos M?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Lupin Limited	$300.0K	6	58.2%
Macleods Pharmaceuticals Limited	$215.2K	6	41.8%

Central DE Medicamentos Y Artigos M sources from 2 verified Indian suppliers across 8 distinct formulations.

What Formulations Does Central DE Medicamentos Y Artigos M Import?

Formulation	Value	Ships
Rifa150+inh75+pzn400+etb275 24x28t gdf rifampicin,isoniazid,pyrazinamide and ethambutol hydrochloride tablets USP 1	$100.0K	2
Rifampin & isoniazid tablets 24x28t rifampin and isoniazid tablets 1 Box = 672	$100.0K	2
Ethambutol hydrochloride dispersible tablets 100MG	$91.9K	3
Rifampicin 150MG isoniazid 75 MG pyrazinamide 400mgand ethambutol hydrochloride 275MG tablets USP 1279 .000 Box 4	$50.0K	1
Drugs & pharmaceuticals harmless medicines rifampicin 75MG/isoniazid 50MG /pyrazinamide 150 MG dispersible tablets	$50.0K	1
Rifampin & isoniazid tablets 24x28 t rifampin and isoniazid tablets 1box= 672	$50.0K	1
Drugs & pharmaceuticals harmless medicines rifampicin 75MG/isoniazid 50MG /pyrazinamide 150 MG dispersible tablets	$45.7K	1
Ethambutol 100MG dispersible tablets (iplus-gdf)	$27.6K	1

Central DE Medicamentos Y Artigos M imports 8 distinct pharmaceutical formulations. Showing top 8 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ethambutol	Tuberculosis Medications	$300.0K	6	0.0%	14
2	Pyrazinamide	Tuberculosis Medications	$150.0K	3	0.0%	9

Central DE Medicamentos Y Artigos M imports 2 pharmaceutical products across 1 categories into Mozambique totaling $450.0K.

Central DE Medicamentos Y Artigos M — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Central de Medicamentos e Artigos Médicos (CMAM) is a governmental institution in Mozambique, established on September 6, 1975, by Presidential Decree n˚13/75. Operating under the Ministry of Health, CMAM is responsible for the planning, acquisition, storage, conservation, and distribution of essential medicines and medical supplies throughout the country. Its mission is to ensure a regular and continuous supply of vital health products to users of the National Health Service. (cmam.gov.mz)

Headquartered in Maputo, CMAM manages a network of central and intermediate warehouses across Mozambique, including facilities in Zimpeto, Machava, Beira, Nampula, Vilankulo, Manica, Mocuba, Mopeia, Ile, and Quelimane. This extensive distribution network enables CMAM to effectively serve the entire national territory, ensuring that essential health products reach even the most remote areas. (cmam.gov.mz)

2Distribution Network

CMAM's distribution network comprises four central warehouses and six intermediate warehouses strategically located across Mozambique. The central warehouses are situated in Zimpeto, Machava, Beira, and Nampula, while the intermediate warehouses are in Vilankulo, Manica, Mocuba, Mopeia, Ile, and Quelimane. This widespread network facilitates efficient storage and distribution of medical supplies, ensuring timely delivery to health units nationwide. (cmam.gov.mz)

The logistics capabilities of CMAM are designed to handle a diverse range of pharmaceutical products, including finished formulations such as tablets, capsules, syrups, and injections. The organization employs a centralized procurement system, coordinating with various suppliers to meet the needs of the National Health Service. CMAM's warehouses are equipped to manage large volumes of medical supplies, ensuring that products are stored under appropriate conditions to maintain their efficacy and safety. (cmam.gov.mz)

3Industry Role

CMAM plays a pivotal role in Mozambique's pharmaceutical supply chain as the primary wholesaler and distributor of essential medicines and medical supplies. By centralizing procurement and distribution, CMAM ensures that health units across the country have access to necessary medical products. This centralized approach allows for standardized quality control and efficient resource allocation, contributing to the overall effectiveness of the National Health Service. (cmam.gov.mz)

In addition to its primary role, CMAM also engages in parallel importing to supplement its supply chain, particularly when there are shortages or specific product requirements. This strategy enables CMAM to diversify its sources and maintain a steady supply of essential health products, thereby enhancing the resilience of the pharmaceutical supply chain in Mozambique. (cmam.gov.mz)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Central DE Medicamentos Y Artigos M

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

CMAM's sourcing strategy involves a diversified network of suppliers to mitigate risks associated with dependency on a single source. While specific data on the number of suppliers is not available, CMAM's extensive distribution network and procurement processes suggest a strategic approach to supplier diversification. By engaging with multiple suppliers, CMAM can ensure a steady supply of essential medicines and medical supplies, reducing the impact of potential disruptions from any single supplier. (cmam.gov.mz)

The shipment data indicates that CMAM maintains stable relationships with its suppliers, as evidenced by the consistent procurement of medical supplies over time. This stability is crucial for maintaining uninterrupted access to essential health products and reflects the effectiveness of CMAM's supplier relationship management. (cmam.gov.mz)

2Supply Chain Resilience

CMAM's supply chain resilience is bolstered by its diversified sourcing strategy, which includes engaging with multiple suppliers to reduce dependency on a single source. This approach allows CMAM to adapt to changes in the global pharmaceutical market and address any supply chain disruptions effectively. Additionally, CMAM's extensive network of warehouses across Mozambique enhances its ability to respond to regional demands and emergencies promptly. (cmam.gov.mz)

Importing Pharmaceuticals into Mozambique — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Mozambique

1Regulatory Authority & Framework

The primary regulatory authority overseeing pharmaceutical imports in Mozambique is the Ministry of Health, which is responsible for establishing and enforcing regulations related to the importation, distribution, and use of medical products. Key legislation governing pharmaceutical imports includes the Medicines and Medical Devices Law, which outlines the requirements for the registration, importation, and distribution of medical products in the country. This law ensures that all imported medical supplies meet the necessary safety, efficacy, and quality standards before they are made available to the public. (cmam.gov.mz)

The marketing authorization pathway for Indian generics involves several steps, including the submission of a registration dossier to the Ministry of Health, which must demonstrate that the product meets the required quality standards. The dossier is evaluated by the National Directorate of Pharmacy and Medicines, which assesses the safety, efficacy, and quality of the product. Upon successful evaluation, the product is granted marketing authorization, allowing it to be imported and distributed within Mozambique. (cmam.gov.mz)

2Import Licensing & GMP

Import licensing requirements in Mozambique stipulate that all pharmaceutical products must be registered with the Ministry of Health before importation. This process involves submitting a comprehensive registration dossier that includes detailed information about the product, its manufacturing process, and quality control measures. The Ministry of Health reviews the dossier to ensure that the product complies with national regulations and international standards. (cmam.gov.mz)

Frequently Asked Questions — Central DE Medicamentos Y Artigos M

What products does Central DE Medicamentos Y Artigos M import from India?

Central DE Medicamentos Y Artigos M imports 2 pharmaceutical products across 1 categories. Top imports: Ethambutol ($300.0K), Pyrazinamide ($150.0K).

Who supplies pharmaceuticals to Central DE Medicamentos Y Artigos M from India?

Central DE Medicamentos Y Artigos M sources from 2 verified Indian suppliers. The primary supplier is Lupin Limited (58.2% of imports, $300.0K).

What is Central DE Medicamentos Y Artigos M's total pharmaceutical import value?

Central DE Medicamentos Y Artigos M's total pharmaceutical import value from India is $450.0K, based on 9 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Central DE Medicamentos Y Artigos M focus on?

Central DE Medicamentos Y Artigos M imports across 1 categories. The largest: Tuberculosis Medications (100.0%).

Get Full Central DE Medicamentos Y Artigos M Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Central DE Medicamentos Y Artigos M

Central DE Medicamentos Y Artigos M — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Central DE Medicamentos Y Artigos M?

What Formulations Does Central DE Medicamentos Y Artigos M Import?

What Products Does Central DE Medicamentos Y Artigos M Import?

Top Products by Import Value

Central DE Medicamentos Y Artigos M Therapeutic Categories — 1 Specializations